Screener
Kura Oncology KURA Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Kura Oncology’s reported figures.
The source filing: Kura Oncology’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219481
FAQ
- What is Kura Oncology's enterprise value?
- Kura Oncology (KURA) reported enterprise value of $703.31M in Q1 2026.
- How has Kura Oncology's enterprise value changed year-over-year?
- Kura Oncology's enterprise value increased by 40.4% year-over-year, from $501.07M to $703.31M.
- What is the long-term trend for Kura Oncology's enterprise value?
- Over 5 years (2020 to 2025), Kura Oncology's enterprise value has grown at a -16.0% compound annual growth rate (CAGR), from $1.85B to $775.47M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Kura Oncology's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude